Danaher Co. (NYSE:DHR - Free Report) - Investment analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for shares of Danaher in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now forecasts that the conglomerate will post earnings of $1.62 per share for the quarter, down from their prior estimate of $2.00. The consensus estimate for Danaher's current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher's Q4 2025 earnings at $2.36 EPS.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the firm posted $2.09 EPS.
Several other equities analysts also recently weighed in on the company. StockNews.com downgraded Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Barclays reduced their target price on Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. The Goldman Sachs Group set a $250.00 target price on Danaher in a report on Wednesday, January 15th. JPMorgan Chase & Co. cut their target price on Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They issued a "buy" rating and a $275.00 price objective for the company. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $278.00.
Get Our Latest Analysis on DHR
Danaher Stock Down 1.8 %
Danaher stock traded down $3.75 during midday trading on Monday, reaching $205.69. The company's stock had a trading volume of 4,305,095 shares, compared to its average volume of 4,597,061. The stock's 50-day simple moving average is $225.41 and its 200-day simple moving average is $245.78. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.83. Danaher has a 52-week low of $196.80 and a 52-week high of $281.70.
Institutional Investors Weigh In On Danaher
A number of hedge funds have recently made changes to their positions in the business. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC lifted its stake in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Insider Activity at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is owned by insiders.
Danaher Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. Danaher's dividend payout ratio (DPR) is presently 24.24%.
About Danaher
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.